Genzyme said in the lawsuit, made public on Monday, that Sarepta mimics Genzyme's technology for modifying viruses used to deliver genes into human cells in gene-therapy treatments like Elevidys.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/o0hsWVE
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment